Browsing Tag
Biofrontera Inc.
2 posts
Is photodynamic therapy ready to move beyond facial use in actinic keratosis care?
Biofrontera Inc.’s Phase 3 Ameluz data extend photodynamic therapy beyond the face. Find out how this could reshape field treatment decisions.
Biofrontera reaches key clinical milestone with database locks across two ongoing studies
Find out why Biofrontera Inc.’s database locks for two clinical studies strengthen regulatory readiness and advance key data milestones.